Bill Snyder

September 9, 2024

Peptide discovery could advance treatment of high blood pressure

VUMC researchers found that peptides modified by highly reactive compounds called isolevuglandins activated T cells and promoted hypertension in mice. Their first-ever isolation of such peptides is a step toward potentially intervening in this pathologic process.

By Bill Snyder
Walter Chazin, PhD, helps Aylar Atadurdyyeva, a student in the Interdisciplinary Graduate Program (IGP) in Biological and Biomedical Sciences, into her lab coat. Atadurdyyeva, who is originally from Turkmenistan, is a graduate of the University of Kansas. (photo by Susan Urmy)
September 4, 2024

New biomedical sciences graduate students encouraged to ‘change the world’ 

The highlight of the ceremony was the presentation of white lab coats to the students. A symbol of academic rigor and scientific excellence, the lab coat also reflects a commitment to benefiting society through research and discovery. 

By Bill Snyder
September 4, 2024

RSV vaccine in older people cuts risk of hospitalization

A multicenter study conducted in 19 states between October 2023 and March 2024 demonstrated that RSV vaccination was 75% effective in preventing RSV-associated hospitalizations for adults age 60 and older.

By Bill Snyder
(Adobe Stock)
August 29, 2024

Study finds human milk component may protect adult intestinal health

The research may lead to new treatments for diseases such as inflammatory bowel disease and mucositis, a severe complication of chemotherapy.

By Bill Snyder
(Adobe Stock)
August 27, 2024

We’re here for you: how to comfort a coworker in grief

How can caregivers be expected to hold the grief of their patients, and their patients’ families, when they are grieving themselves? That was the question addressed at a recent panel discussion at Vanderbilt.

By Bill Snyder
(iStock)
August 13, 2024

VUMC, DOD join forces for a hantavirus antibody “sprint”

VUMC’s antibody collaboration with the DOD goes back to 2018, when the medical center signed a five-year cooperative agreement with the U.S. Defense Advanced Research Projects Agency to develop protective treatments that can be rushed to health care providers within weeks after a viral outbreak.

By Bill Snyder
August 8, 2024

Aspirnaut research interns reach for the stars

The next day, the students, interns in the 16th summer research session of the Aspirnaut STEM pipeline program for diversity, were bound for the University of Virginia in Charlottesville.
By Bill Snyder
August 8, 2024

VA honors Robert Dittus for health professions education

He is the first from VUMC to receive the award, which recognizes “champions” of health professions education who have advanced the VA’s health care education mission.
By Bill Snyder
August 6, 2024

Guide to a healthier, longer life: Get up and get moving

In a study of predominantly low-income and Black Americans ages 65 and older, the researchers found that those with the longest “sitting time” — more than 10 hours a day — had the highest mortality risk.
By Bill Snyder
August 2, 2024

White matter may aid recovery from spinal cord injuries: study

The research could lead to treatments that restore nerve activity through the targeted delivery of electromagnetic stimuli or drugs.
By Bill Snyder
July 29, 2024

Study sheds new light on autism, but there’s more work to be done

A target of their investigations is serotonin, a signaling molecule that is well known for its critical roles in regulating mood and which also plays an important role in the development of the brain and nervous system.
By Bill Snyder
July 22, 2024

Opioid treatment can avoid foster care placement: study

If women are given medications to treat opioid use disorder during their pregnancy they are significantly more likely to retain custody of their newborns after delivery
By Bill Snyder
1 … 8 9 10 11 12 … 115